<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34851455</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1613-7671</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>Suppl 7</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Wiener klinische Wochenschrift</Title><ISOAbbreviation>Wien Klin Wochenschr</ISOAbbreviation></Journal><ArticleTitle>[Guideline S1: Long COVID: Diagnostics and treatment strategies].</ArticleTitle><Pagination><StartPage>237</StartPage><EndPage>278</EndPage><MedlinePgn>237-278</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00508-021-01974-0</ELocationID><Abstract><AbstractText>This guideline comprises the state of science at the time of the editorial deadline. In view of the high turnover of knowledge the guideline is designed as a&#xa0;living guideline. The main objective was to provide a&#xa0;tool for the use in primary care, being considered well suited as a&#xa0;first point of entry and for the provision of care. The guideline gives recommendations on the differential diagnosis of symptoms following SARS-CoV&#x2011;2 infection, on their therapeutic options, as well as for guidance and care of the patients concerned. It also offers advice concerning return to daily life and rehabilitation. Long COVID being a&#xa0;very variable condition, we chose an interdisciplinary approach.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rabady</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3603-5841</Identifier><AffiliationInfo><Affiliation>Department Allgemeine Gesundheitsstudien, Kompetenzzentrum f&#xfc;r Allgemein- und Familienmedizin, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Dr. Karl-Dorrek-Stra&#xdf;e&#xa0;30, 3500, Krems, &#xd6;sterreich. susanne.rabady@kl.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altenberger</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pensionsversicherungsanstalt, Rehabilitationszentrum Gro&#xdf;gmain, Gro&#xdf;gmain, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brose</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4902-4463</Identifier><AffiliationInfo><Affiliation>Department Allgemeine Gesundheitsstudien, Kompetenzzentrum f&#xfc;r Allgemein- und Familienmedizin, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Dr. Karl-Dorrek-Stra&#xdf;e&#xa0;30, 3500, Krems, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denk-Linnert</LastName><ForeName>Doris-Maria</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Klinische Abteilung Phoniatrie-Logop&#xe4;die, Universit&#xe4;tsklinik f&#xfc;r Hals&#x2011;, Nasen- und Ohrenkrankheiten, Medizinische Universit&#xe4;t Wien, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fertl</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurologische Abteilung, Klinik Landstra&#xdf;e, Wiener Gesundheitsverbund, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;tzinger</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Kinder- und Jugendheilkunde, Klinik Ottakring, Wiener Gesundheitsverbund, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Cruz Gomez Pellin</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit Versorgungsforschung in der Prim&#xe4;rversorgung, Zentrum f&#xfc;r Public Health, Medizinische Universit&#xe4;t Wien, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofbaur</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Praxis Dr. Hofbaur, Arbesbach, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8760-4250</Identifier><AffiliationInfo><Affiliation>Unit Health Services Research and Telemedicine in Primary Care, Department of Preventive- and Social Medicine, Center for Public Health, Medical University of Vienna, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann-Dorninger</LastName><ForeName>Renate</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Praxis Dr. Hoffmann-Dorninger, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koczulla</LastName><ForeName>Rembert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Pneumologische Rehabilitation, Philipps Universit&#xe4;t Marburg, Marburg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lammel</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0641-7678</Identifier><AffiliationInfo><Affiliation>Praxis Dr Oliver Lammel, Ramsau am Dachstein, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamprecht</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3365-3449</Identifier><AffiliationInfo><Affiliation>Klinik f&#xfc;r Lungenheilkunde, Kepler Universit&#xe4;tsklinikum, Linz, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;ffler-Ragg</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Innere Medizin II, Innsbruck, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Christian A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-6172-5417</Identifier><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Hals&#x2011;, Nasen- und Ohrenkrankheiten, Medizinische Universit&#xe4;t Wien, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poggenburg</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6233-3455</Identifier><AffiliationInfo><Affiliation>Ordination Dr. Stephanie Poggenburg, Hart bei Graz, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rittmannsberger</LastName><ForeName>Hans</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6567-4677</Identifier><AffiliationInfo><Affiliation>Abteilung Psychiatrie und Psychotherapie, Pyhrn-Eisenwurzen-Klinikum, Steyr, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sator</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dermatologische Abteilung, Klinik Hietzing, Wiener Gesundheitsverbund, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strenger</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Kinder- und Jugendheilkunde, Medizinische Universit&#xe4;t Graz, Graz, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vonbank</LastName><ForeName>Karin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2930-7252</Identifier><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Pulmologie, Universit&#xe4;tsklinik f&#xfc;r Innere Medizin II, Medizinische Universit&#xe4;t Wien, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wancata</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4951-6780</Identifier><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Sozialpsychiatrie, Medizinische Universit&#xe4;t Wien, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Innere Medizin 2 (Kardiologie, Intensivmedizin), Klinikum Wels-Grieskirchen, Wels, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>J&#xf6;rg</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Klinikum Klagenfurt, Feschnigstra&#xdf;e&#xa0;11, 9020, Klagenfurt, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>G&#xfc;nter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Univ.-Klinik f&#xfc;r Innere Medizin II, Medizinische Universit&#xe4;t&#xa0;Innsbruck, Innsbruck, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendler</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3660-5637</Identifier><AffiliationInfo><Affiliation>Department Allgemeine Gesundheitsstudien, Kompetenzzentrum f&#xfc;r Allgemein- und Familienmedizin, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Dr. Karl-Dorrek-Stra&#xdf;e&#xa0;30, 3500, Krems, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwick</LastName><ForeName>Ralf-Harun</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Ambulante internistische Rehabilitation, Therme Wien Med, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Wien Klin Wochenschr</MedlineTA><NlmUniqueID>21620870R</NlmUniqueID><ISSNLinking>0043-5325</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Die vorliegende Leitlinie S1 fasst den Stand der Kenntnis zu Long COVID zum Zeitpunkt des Redaktionsschlusses zusammen. Aufgund der starken Dynamik der Wissensentwicklung versteht sie sich als &#x201e;living guideline&#x201c;. Der Schwerpunkt liegt auf der praktischen Anwendbarkeit auf der Ebene der haus&#xe4;rztlichen Prim&#xe4;rversorgung, die als geeignete Stelle f&#xfc;r den Erstzutritt und f&#xfc;r die prim&#xe4;re Betreuung und Behandlung verstanden wird. Die Leitlinie gibt Empfehlungen zur Differenzialdiagnostik der h&#xe4;ufigsten Symptome, die in der Folge einer Infektion mit SARS-CoV&#x2011;2 auftreten k&#xf6;nnen, zu therapeutischen Optionen, zu Patient:innenf&#xfc;hrung und -betreuung, sowie zu Wiedereingliederung in den Alltag, und die Rehabilitation. Entsprechend des Krankheitsbildes ist die Leitlinie in einem interdisziplin&#xe4;ren Prozess entstanden und gibt Empfehlungen zu Schnittstellen und Kooperationsm&#xf6;glichkeiten.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Behandlung</Keyword><Keyword MajorTopicYN="N">COVID-Folgen</Keyword><Keyword MajorTopicYN="N">Diagnostik</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Postinfekti&#xf6;ses Syndrom</Keyword><Keyword MajorTopicYN="N">Primary care</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34851455</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="doi">10.1007/s00508-021-01974-0</ArticleId><ArticleId IdType="pii">10.1007/s00508-021-01974-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a&#xa0;cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR Themed Review . Living with Covid19&#x2014;second review. 2021.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2020 doi: 10.1101/2020.12.24.20248802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceravolo MG, Arienti C, de Sire A, Andrenelli E, Negrini F, Lazzarini SG, et al. Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review. Eur J Phys Rehabil Med. 2020;56(5):642&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">32705860</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V. Scientists set out to connect the dots on long COVID. Nat Methods. 2021;18(5):449&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12):ofaa509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . NICE guideline (NG188): COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2013;6&#xa0;months after COVID-19 in non-hospitalised subjects: a&#xa0;population-based cohort study. Thorax. 2021;76(4):405&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3&#xa0;months after a&#xa0;SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73(3):e826&#x2013;e829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Dobler CC, Bell K, Rojas DP, Clark J, McLaws M-L, et al. Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19&#xa0;cases: systematic review. PLoS ONE. 2021;16(4):e0248946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8018669</ArticleId><ArticleId IdType="pubmed">33798211</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Schiabor Barrett KM, Riffle S, Bolze A, Neveux I, Dabe S, et al. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020 doi: 10.1101/2020.10.07.20208702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015&#x2013;2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a&#xa0;multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1externalicon.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1externalicon</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P, Arora U, Kumar A, Wig N. The &#x201c;post-COVID&#x201d; syndrome: How deep is the damage? J Med Virol. 2021;93(2):673&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A, Hepgul N, Nikkheslat N, Borsini A, Zajkowska Z, Moll N, et al. Persistent fatigue induced by interferon-alpha: a&#xa0;novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology. 2019;100:276&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350004</ArticleId><ArticleId IdType="pubmed">30567628</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A, Schurman SH, Franceschi C, Ferrucci L. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17(1):23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443812</ArticleId><ArticleId IdType="pubmed">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemian N, Kao D, Pakpour S. Fecal microbiota transplantation during and post-COVID-19 pandemic. Int J Mol Sci. 2021;22(6):3004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998826</ArticleId><ArticleId IdType="pubmed">33809421</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302&#x2013;1310.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;955.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol. 2008;4(9):491&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703183</ArticleId><ArticleId IdType="pubmed">18756274</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5920070</ArticleId><ArticleId IdType="pubmed">29736302</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Wang Y, Li J, Han H, Xia Z, Liu F, et al. Decreased T cell populations contribute to the increased severity of COVID-19. Clin Chim Acta. 2020;508:110&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219428</ArticleId><ArticleId IdType="pubmed">32405080</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Chen F, Ou Z, Fan Q, Tan X, Wang Y, et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol. 2020;17(11):1119&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Han J, Cheng X, Yu L, Zhang L, Wang W, et al. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19&#xa0;patients. Sci Rep. 2020;10(1):17718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573596</ArticleId><ArticleId IdType="pubmed">33077873</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. &#x2018;Long-COVID&#x2019;: a&#xa0;cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, Jia JL, Li LM, Mao HL, Zhou XM, Luo H, Gao YF, Xu AG. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15(11):e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal G, Yadav S, Kumar R. Post-intensive care syndrome: an overview. J Transl Int Med. 2017;5(2):90&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo A, Pereira-Vaz J, Mota V, Mendes A, Morais C, da Silva AC, et al. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. J Med Virol. 2020;92(10):2227&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301002</ArticleId><ArticleId IdType="pubmed">32484958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandetu T-B, Dziuban EJ, Sikuvi K, Beard RS, Nghihepa R, van Rooyen G, et al. Persistence of positive RT-PCR results for over 70 days in two travelers with COVID-19. Disaster Med Public Health Prep. 2020 doi: 10.1017/dmp.2020.450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2020.450</ArticleId><ArticleId IdType="pmc">PMC7884651</ArticleId><ArticleId IdType="pubmed">33208199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Huang K, Jiang H, Hua L, Yu W, Ding D, et al. Long-term existence of SARS-CoV-2 in COVID-19 patients: host immunity, viral virulence, and transmissibility. Virol Sin. 2020;35(6):793&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644793</ArticleId><ArticleId IdType="pubmed">33156486</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken PA, Stallmach A, Pletz MW, Brandt C, Andreas N, Hahnfeld S, et al. Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. Leukemia. 2021;35(3):920&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893131</ArticleId><ArticleId IdType="pubmed">33608636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirotsu Y, Maejima M, Shibusawa M, Amemiya K, Nagakubo Y, Hosaka K, et al. Analysis of a&#xa0;persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. J Infect Chemother. 2021;27(2):406&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598429</ArticleId><ArticleId IdType="pubmed">33183963</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S-K, Lee C-W, Park D-I, Woo H-Y, Cheong HS, Shin HC, et al. Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID-19 in Korea. Clin Gastroenterol Hepatol. 2021;19(7):1387&#x2013;1394.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286243</ArticleId><ArticleId IdType="pubmed">32534042</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6(31):eabc5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu A, Fischbein N, Wintermark M, Zaharchuk G, Yun PT, Zeineh M. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology. 2021;63(1):147&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490479</ArticleId><ArticleId IdType="pubmed">32930820</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Debeaumont D, Boujibar F, Ferrand-Devouge E, Artaud-Macari E, Tamion F, Gravier FE, et al. Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalization&#x2014;a pilot study. Phys Ther. 2021;101(6):pzab099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989156</ArticleId><ArticleId IdType="pubmed">33735374</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299(1):E177&#x2013;E186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a&#xa0;prospective study. Lancet Respir Med. 2021;9(7):747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021;9(1):107&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AU, Devaraj A, Desai SR. Interstitial lung disease after COVID-19 infection: a catalog of uncertainties. Radiology. 2021;299(1):E216&#x2013;E218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841875</ArticleId><ArticleId IdType="pubmed">33502279</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidbreder A, Sonnweber T, Stefani A, Ibrahim A, Cesari M, Bergmann M, et al. Video-polysomnographic findings after acute COVID-19: REM sleep without atonia as sign of CNS pathology? Sleep Med. 2021;80:92&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7985859</ArticleId><ArticleId IdType="pubmed">33588262</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group Four-month clinical status of a&#xa0;cohort of patients after hospitalization for COVID-19. JAMA. 2021;325(15):1525&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a&#xa0;prospective, community-based study. BMJ Open. 2021;11(3):e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla A, Ankermann T, Behrends U, Berlit P, B&#xf6;ing S, Brinkmann F, et al. S1-Leitlinie Post-COVID/Long-COVID. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. Long-haul post COVID-19 symptoms presenting as a&#xa0;variant of postural orthostatic tachycardia syndrome. JACC Case Rep. 2021;3(4):573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a&#xa0;report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021;23(3):352&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">33605000</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a&#xa0;port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology. 2021;96(4):e575&#x2013;e586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlit P, et al. Neurologische Manifestationen bei COVID-19, S1-Leitlinie. Berlin: Deutsche Gesellschaft f&#xfc;r Neurologie; 2021.</Citation></Reference><Reference><Citation>Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr&#xe9; syndrome. Brain. 2020;144(2):682&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799186</ArticleId><ArticleId IdType="pubmed">33313649</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain&#x2013;Barr&#xe9; syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73&#xa0;cases. J Neurol. 2021;268(4):1133&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445716</ArticleId><ArticleId IdType="pubmed">32840686</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schr&#xf6;ter N, Bormann T, Thurow J, Wagner D, Frings L, et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med. 2021;62(7):910&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto OH, Wu S, Mera RM, Costa AF, Recalde BY, Issa NP. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur J Neurol. 2021;28(10):3245&#x2013;3253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Rodr&#xed;guez-Jim&#xe9;nez J, Fuensalida-Novo S, Palacios-Ce&#xf1;a M, G&#xf3;mez-Mayordomo V, Florencio LL, et al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. Pain. 2021 doi: 10.1097/j.pain.0000000000002306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002306</ArticleId><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Heu&#xdf; D, et al. Diagnostik und Differenzialdiagnose bei Myalgien, S1-Leitlinie. Berlin: Deutsche Gesellschaft f&#xfc;r Neurologie; 2020.</Citation></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144(4):1263&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, Shikotra A, Singapuri A, Sereno M, et al. Physical, cognitive and mental health impacts of COVID-19 following hospitalisation&#x2014;a multi-centre prospective cohort study. medRxiv. 2021 doi: 10.1101/2021.03.22.21254057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254057</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xfc;&#xdf; H. Langzeitfolgen von COVID&#x2011;19. 2021. https://www.neurodiem.at/news/langzeitfolgen-von-covid-19-5cTFQ5DN2eONaO9FrgZ191. Zugegriffen: 10. Mai 2021.</Citation></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, et al. Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study. Eur J Neurol. 2021;28(10):3348&#x2013;3359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya J, Islam MA, Abdullah B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): a meta-analysis of 27,492 patients. Laryngoscope. 2021;131(4):865&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753439</ArticleId><ArticleId IdType="pubmed">33219539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucidi D, Molinari G, Silvestri M, De Corso E, Guaraldi G, Mussini C, et al. Patient-reported olfactory recovery after SARS-CoV-2 infection: a 6-month follow-up study. Int Forum Allergy Rhinol. 2021;11(8):1249&#x2013;1252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33539667</ArticleId></ArticleIdList></Reference><Reference><Citation>Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J, et al. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6&#xa0;months case-control study of health workers. Eur Arch Otorhinolaryngol. 2021;278(12):4831&#x2013;4837. doi: 10.1007/s00405-021-06764-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06764-y</ArticleId><ArticleId IdType="pmc">PMC8004560</ArticleId><ArticleId IdType="pubmed">33774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Sabha M, Damm M, Philpott C, Oleszkiewicz A, H&#xe4;hner A, et al. Parosmia is associated with relevant olfactory recovery after olfactory training. Laryngoscope. 2021;131(3):618&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">33210732</ArticleId></ArticleIdList></Reference><Reference><Citation>AWMF. S2k-Leitlinie 017/050: Riech- und Schmeckst&#xf6;rungen. 2021. https://www.awmf.org/uploads/tx_szleitlinien/017-050l_S2k_Riech-und-Schmeckst%C3%B6rungen_2021-04.pdf. Zugegriffen: 28. Juni 2021.</Citation></Reference><Reference><Citation>Cantarella G, Ald&#xe8; M, Consonni D, Zuccotti G, Berardino FD, Barozzi S, et al. Prevalence of dysphonia in non hospitalized patients with COVID-19 in Lombardy, the Italian epicenter of the pandemic. J Voice. 2021 doi: 10.1016/j.jvoice.2021.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2021.03.009</ArticleId><ArticleId IdType="pmc">PMC7955941</ArticleId><ArticleId IdType="pubmed">33766419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadd K, Moyse K, Enderby P. Impact of COVID-19 on the speech and language therapy profession and their patients. Front Neurol. 2021;12(96):629190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930219</ArticleId><ArticleId IdType="pubmed">33679590</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziewas R, Hufelschulte LM, Lepper J, Sackarnd J, Minnerup J, Teismann I, et al. Dysphagia in patients with severe coronavirus disease 2019-potential neurologic etiologies. Crit Care Explor. 2021;3(1):e0332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837983</ArticleId><ArticleId IdType="pubmed">33521647</ArticleId></ArticleIdList></Reference><Reference><Citation>Aviv JE, Chandrasekhar S, Thomashow B. Covid-19 era post viral vagal neuropathy presenting as persistent shortness of breath with normal pulmonary imaging. Int J Pul Res Sci. 2020;4(4):555641. doi: 10.19080/IJOPRS.2020.04.555641.</Citation><ArticleIdList><ArticleId IdType="doi">10.19080/IJOPRS.2020.04.555641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiekens C, Boldrini P, Andreoli A, Avesani R, Gamna F, Grandi M, et al. Rehabilitation and respiratory management in the acute and early post-acute phase. &#x201c;Instant paper from the field&#x201d; on rehabilitation answers to the COVID-19 emergency. Eur J Phys Rehabil Med. 2020;56(3):323&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">32293817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Cabaraux P, Mat Q, Huet K, Harmegnies B, et al. Features of mild-to-moderate COVID-19 patients with dysphonia. J Voice. 2020 doi: 10.1016/j.jvoice.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7269945</ArticleId><ArticleId IdType="pubmed">32600873</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodsky MB, Gilbert RJ. The long-term effects of COVID-19 on dysphagia evaluation and treatment. Arch Phys Med Rehabil. 2020;101(9):1662&#x2013;1664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286637</ArticleId><ArticleId IdType="pubmed">32534801</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson JM, Govender R, Roe J, Clunie G, Murphy J, Brady G, et al. COVID-19 and ENT SLT services, workforce and research in the UK: a discussion paper. Int J Lang Commun Disord. 2020;55(5):806&#x2013;817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436215</ArticleId><ArticleId IdType="pubmed">32770652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan R, Mohapatra B. Shedding light on dysphagia associated with COVID-19: the what and why. OTO Open. 2020;4(2):2473974X20934770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281885</ArticleId><ArticleId IdType="pubmed">32551409</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, O&#x2019;Hara M, Evans S, Agyen L, et al. Long COVID guidelines need to reflect lived experience. Lancet. 2021;397(10273):455&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer SK, Iezzi CM, Gilpin L. Swallowing and voice outcomes in patients hospitalized with COVID-19: an observational cohort study. Arch Phys Med Rehabil. 2021;102(6):1084&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846878</ArticleId><ArticleId IdType="pubmed">33529610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289736</ArticleId><ArticleId IdType="pubmed">32535294</ArticleId></ArticleIdList></Reference><Reference><Citation>Welge-Luessen A, Hummel T, Stojan T, Wolfensberger M. What is the correlation between ratings and measures of olfactory function in patients with olfactory loss? Am J Rhinol. 2005;19(6):567&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">16402642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller CA, Grassinger E, Naka A, Temmel AFP, Hummel T, Kobal G. A self-administered odor identification test procedure using the &#x201c;Sniffin&#x2019; Sticks&#x201d;. Chem Senses. 2006;31(6):595&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">16754696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, et al. Position paper on olfactory dysfunction. Rhinology. 2016;56(1):1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28623665</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleszkiewicz A, Schriever VA, Croy I, H&#xe4;hner A, Hummel T. Updated Sniffin&#x2019; Sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol. 2019;276(3):719&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411676</ArticleId><ArticleId IdType="pubmed">30554358</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Besser G, Renner B, Seyferth S, Hummel T, Mueller CA. Retronasal olfactory function in patients with smell loss but subjectively normal flavor perception. Laryngoscope. 2020;130(7):1629&#x2013;1633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318622</ArticleId><ArticleId IdType="pubmed">31471971</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese G, Moltrasio C, Berti E, Marzano AV. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology. 2021;237(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801998</ArticleId><ArticleId IdType="pubmed">33232965</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA. Fact sheet for healthcare providers administering vaccine (vaccination PROVIDERS). 2021. https://www.fda.gov/media/144413/download. Zugegriffen: 26. Juni 2021.</Citation></Reference><Reference><Citation>Tan SW, Tam YC, Oh CC. Skin manifestations of COVID-19: a worldwide review. JAAD Int. 2021;2:119&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7754879</ArticleId><ArticleId IdType="pubmed">33479703</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, et al. Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, et al. Long COVID in the skin: a&#xa0;registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21(3):313&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeck M, Herman A. COVID toes: Where do we stand with the current evidence? Int J Infect Dis. 2021;102:53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566763</ArticleId><ArticleId IdType="pubmed">33075530</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, Kastritis E, Fotiou D, et al. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J Infect. 2021;83(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R, Balanz&#xe1;-Mart&#xed;nez V, Luperdi SC, Estrada I, Latorre A, Gonz&#xe1;lez-Jim&#xe9;nez P, et al. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern Med. 2021;290(3):621&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Cristillo V, Piccinelli SC, Zoppi N, Bonzi G, Sattin D, et al. COVID-19 severity impacts on long-term neurological manifestation after hospitalisation. medRxiv. 2021 doi: 10.1101/2020.12.27.20248903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.27.20248903</ArticleId></ArticleIdList></Reference><Reference><Citation>Jebrini T, Reinhard MA, Ortmann M, Strupf M, R&#xfc;b M, Padberg F, et al. Psychiatric complications of COVID-19: the unknown disease (long covid) MMW Fortschr Med. 2021;163(9):48&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103131</ArticleId><ArticleId IdType="pubmed">33961259</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, Pallar&#xe9;s JG, Buend&#xed;a-Romero &#xc1;, Mart&#xed;nez-Cava A, Franco-L&#xf3;pez F, S&#xe1;nchez-Alcaraz Mart&#xed;nez BJ, et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. 2021;18(10):5329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A, Brito-Zer&#xf3;n P, Conangla Ferr&#xed;n L, Kostov B, Moragas Moreno A, Mestres J, et al. Long Covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18(8):4350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F, Mazza M, Cavalli G, Ciceri F, Dagna L, Rovere-Querini P. Can cytokine blocking prevent depression in COVID-19 survivors? J Neuroimmune Pharmacol. 2021;16(1):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587545</ArticleId><ArticleId IdType="pubmed">33107012</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R, Cinel E, Cilla M, Compagnone N, Ferrante M, Falbo E, Patrizi A, Castellani J, Magnaghi C, Calvisi SL, Arcidiacono T, Lanzani CL, Canti V, Mazza MG, Martinenghi S, Vitali G, Benedetti F, Ciceri F, Conte C, Rovere Querini P. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors. Panminerva Med. 2021 doi: 10.23736/S0031-0808.21.04399-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0031-0808.21.04399-8</ArticleId><ArticleId IdType="pubmed">34060280</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatric Research Unit, WHO Collaborating Center for Mental Healt. WHO (F&#xfc;nf) &#x2013; Fragebogen zum Wohlbefinden (Version 1998). 1998. https://www.psykiatri-regionh.dk/who-5/Documents/WHO5_German.pdf. Zugegriffen: 16.08.21</Citation></Reference><Reference><Citation>Wikipedia. GAD&#x2011;2. 2011. https://de.wikipedia.org/wiki/GAD-2#/media/Datei:GAD-2.tif. Zugegriffen: 16.8.21</Citation></Reference><Reference><Citation>Sch&#xe4;fer I, Schulze C. Deutsche Version des &#x201c;Primary Care Posttraumatic Stress Disorder screening questionnaire&#x201d;. 2021.</Citation></Reference><Reference><Citation>Baumgartner JS, Jahn R, Friedrich F, Alexandrowicz RW, Wancata J. Die Kriteriumsvalidit&#xe4;t der 15-Item Geriatrischen Depressionsskala in der &#xf6;sterreichischen Bev&#xf6;lkerung. Psychiatr Prax. 2019;46(04):206&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">30641611</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrowicz R, Weiss M, Marquart B, Wancata J. Zur Validit&#xe4;t eines zweistufigen Screenings am Beispiel des Depressionsscreening. Psychiatr Prax. 2008;35(06):294&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">18504689</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapra A, Bhandari P. Chronic fatigue syndrome. Treasure Island: StatPearls; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">32491608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond) 2005;55(1):20&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a&#xa0;narrative review. Ther Adv Infect Dis. 2021;8:20499361211009385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzinger F, Santiago-Garc&#xed;a B, Noguera-Juli&#xe1;n A, Lanaspa M, Lancella L, Cal&#xf2; Carducci FI, et al. COVID-19 in children and adolescents in Europe: a&#xa0;multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316447</ArticleId><ArticleId IdType="pubmed">32593339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702.</Citation><ArticleIdList><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Roland D, De Rose C, V&#xe1;squez-Hoyos P, Ramly B, Chakakala-Chaziya JN, et al. Schools closures during the COVID-19 pandemic: a catastrophic global situation. Pediatr Infect Dis J. 2021;40(4):e146&#x2013;e150.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464019</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110(3):914&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607&#x2013;1608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a&#xa0;pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968&#x2013;981.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID&#x2011;19. 2020. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Zugegriffen: 25. Juni 2021.</Citation></Reference><Reference><Citation>Rubens JH, Akindele NP, Tschudy MM, Sick-Samuels AC. Acute covid-19 and multisystem inflammatory syndrome in children. BMJ. 2021;372:n385.</Citation><ArticleIdList><ArticleId IdType="pubmed">33648933</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood R, Allin B, Jones CE, Whittaker E, Ramnarayan P, Ramanan AV, et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a&#xa0;national Delphi process. Lancet Child Adolesc Health. 2021;5(2):133&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500943</ArticleId><ArticleId IdType="pubmed">32956615</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Andre MC, Grazioli S, Sch&#xf6;bi N, Ritz N, Aebi C, et al. Best practice recommendations for the diagnosis and management of children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS; multisystem inflammatory syndrome in children, MIS-C) in Switzerland. Front Pediatr. 2021;9:667507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8187755</ArticleId><ArticleId IdType="pubmed">34123970</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A, Davison J, Tarrant R, Ross D, Halpin S, Simms A, et al. A multidisciplinary NHS COVID-19 service to manage post-COVID-19 syndrome in the community. J Prim Care Community Health. 2021;12:21501327211010994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C, Caravita S, Faini A, Perego GB, Senni M, Badano LP, et al. Impact of COVID-19 on exercise pathophysiology: a&#xa0;combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021;130(5):1470&#x2013;1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143785</ArticleId><ArticleId IdType="pubmed">33764166</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A, Dannerbeck L, Lange TJ, Pfeifer M, Blaas S, Salzberger B, et al. Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidiscip Respir Med. 2021;16(1):732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, Zhou F, Linchausen DW, Hansen B-A, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger K, Gehrke-Beck S, Holzinger F, Heintze C. DEGAM Leitlinie Husten, Kurzversion. 2021.</Citation></Reference><Reference><Citation>Abholz H, Jendyk R. DEGAM Leitlinie &#x201e;Akuter Schwindel&#x201c;, Kurzversion. 2016.</Citation></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r Allgemeinmedizin und Familienmedizin . Insomnie bei Erwachsenen &#x2013; DEGAM-Anwenderversion zur S3 Leitlinie &#x201e;Nicht erholsamer Schlaf/Schlafst&#xf6;rungen&#x201c;. Berlin: DEGAM; 2017.</Citation></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r Schlafforschung und Schlafmedizin . S3-Leitlinie Nicht erholsamer Schlaf/Schlafst&#xf6;rungen &#x2013; Schlafbezogene Atmungsst&#xf6;rungen. 2016.</Citation></Reference><Reference><Citation>Robert Koch-Institut. COVID&#x2011;19: Entlassungskriterien aus der Isolierung. 2021. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Entlassmanagement.html. Zugegriffen: 1. Juni 2021.</Citation></Reference><Reference><Citation>Rabady S, Hoffmann K, Brose M, Lammel O, Poggenburg S, Redlberger-Fritz M, et al. Symptoms and risk factors for hospitalization of COVID-19 presented in primary care. medRxiv. 2021 doi: 10.1101/2021.03.26.21254331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.26.21254331</ArticleId><ArticleId IdType="pmc">PMC8852901</ArticleId><ArticleId IdType="pubmed">35149931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chmiel C. medix factsheet: long covid/PASC (post acute sequelae of SARS-CoV-2 infection) 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33834881</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am Heart J Plus. 2021;5:100025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Abonie US, Edwards AM, Hettinga FJ. Optimising activity pacing to promote a&#xa0;physically active lifestyle in medical settings: a narrative review informed by clinical and sports pacing research. J Sports Sci. 2020;38(5):590&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">31997716</ArticleId></ArticleIdList></Reference><Reference><Citation>World Physiotherapy. World Physiotherapy briefing paper focuses on safe rehabilitation for people living with long COVID. 2021. https://world.physio/news/world-physiotherapy-briefing-paper-focuses-safe-rehabilitation-people-living-long-covid. Zugegriffen: 13. Juli 2021.</Citation></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18(5):799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Puchner B, Sahanic S, Kirchmair R, Pizzini A, Sonnweber B, W&#xf6;ll E, et al. Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study. Eur J Phys Rehabil Med. 2021;57(2):189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">33448756</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M, Pikart LK, Reimann H, Burkert S, G&#xf6;ktas &#xd6;, Haxel B, et al. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope. 2014;124(4):826&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference><Reference><Citation>Altundag A, Cayonu M, Kayabasoglu G, Salihoglu M, Tekeli H, Saglam O, et al. Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope. 2015;125(8):1763&#x2013;1766.</Citation><ArticleIdList><ArticleId IdType="pubmed">26031472</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Pellegrino R, Sabha M, Altundag A, Damm M, Poletti SC, et al. Factors associated with relevant olfactory recovery after olfactory training: a retrospective study including 601 participants. Rhinology. 2020 doi: 10.4193/Rhin20.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.262</ArticleId><ArticleId IdType="pubmed">32901616</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinc AS, Sengezer T, Cayonu M, Sahin MM. Smoking cessation improves olfactory functions. Laryngoscope. 2020;130(2):E35&#x2013;E38.</Citation><ArticleIdList><ArticleId IdType="pubmed">30953390</ArticleId></ArticleIdList></Reference><Reference><Citation>Pence TS, Reiter ER, DiNardo LJ, Costanzo RM. Risk factors for hazardous events in olfactory-impaired patients. JAMA Otolaryngol Head Neck Surg. 2014;140(10):951&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">25170573</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL. Neuropsychiatric complications of COVID-19. Curr Psychiatry Rep. 2021;23(5):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962429</ArticleId><ArticleId IdType="pubmed">33725218</ArticleId></ArticleIdList></Reference><Reference><Citation>DGPPN. B&#xc4;K. KBV. AWMF . S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression Kurzfassung. 2 2017.</Citation></Reference><Reference><Citation>Salman D, Vishnubala D, Le Feuvre P, Beaney T, Korgaonkar J, Majeed A, et al. Returning to physical activity after covid-19. BMJ. 2021;372:m4721.</Citation><ArticleIdList><ArticleId IdType="pubmed">33419740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long covid. BMJ. 2021;373:n853.</Citation><ArticleIdList><ArticleId IdType="pubmed">33795224</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott N, Martin R, Heron N, Elliott J, Grimstead D, Biswas A. Infographic. Graduated return to play guidance following COVID-19 infection. Br J Sports Med. 2020;54(19):1174&#x2013;1175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371566</ArticleId><ArticleId IdType="pubmed">32571796</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharhag J, Niebauer J, Schobersberger W. &#x201e;Return to Sports&#x201c; im (Hoch&#x2011;)Leistungssport nach COVID-19, Konsensus der sportmedizinischen Universit&#xe4;ts- und Landesinstitute Wien, Salzburg und Innsbruck. 2020.</Citation></Reference><Reference><Citation>Berrisch-Rahmel S. COVID&#x2011;19 und return to play. 2020. https://sportaerztezeitung.com/rubriken/training/1050/covid-19-und-return-to-play/. Zugegriffen: 1. Juni 2021.</Citation></Reference><Reference><Citation>Pelliccia A, Solberg EE, Papadakis M, Adami PE, Biffi A, Caselli S, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC) Eur Heart J. 2019;40(1):19&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">30561613</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellhorn P, Klingel K, Burgstahler C. Return to sports after COVID-19 infection. Eur Heart J. 2020;41(46):4382&#x2013;4384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314071</ArticleId><ArticleId IdType="pubmed">32432700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, Leitl D, Jarosch I, Schneeberger T, Nell C, Stenzel N, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021;7(2):00108-2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielmanns M, Pekacka-Egli A-M, Schoendorf S, Windisch W, Hermann M. Effects of a&#xa0;comprehensive pulmonary rehabilitation in severe post-COVID-19 patients. Int J Environ Res Public Health. 2021;18(5):2695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967422</ArticleId><ArticleId IdType="pubmed">33800094</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Chikhanie Y, Veale D, Schoeffler M, P&#xe9;pin JL, Verges S, H&#xe9;rengt F. Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respir Physiol Neurobiol. 2021;287:103639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879818</ArticleId><ArticleId IdType="pubmed">33588090</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a&#xa0;stakeholders&#x2019; conference. Crit Care Med. 2012;40(2):502&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistarini C, Fiabane E, Houdayer E, Vassallo C, Manera MR, Alemanno F. Cognitive and emotional disturbances due to COVID-19: an exploratory study in the rehabilitation setting. Front Neurol. 2021;12:500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8165252</ArticleId><ArticleId IdType="pubmed">34079511</ArticleId></ArticleIdList></Reference><Reference><Citation>Piquet V, Luczak C, Seiler F, Monaury J, Martini A, Ward AB, et al. Do patients with COVID-19 benefit from rehabilitation? Functional outcomes of the first 100 patients in a&#xa0;COVID-19 rehabilitation unit. Arch Phys Med Rehabil. 2021;102(6):1067&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857995</ArticleId><ArticleId IdType="pubmed">33548208</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese M, Garofano M, Palumbo R, Di Pietro P, Izzo C, Damato A, et al. Exercise training and cardiac rehabilitation in COVID-19 patients with cardiovascular complications: state of art. Life. 2021;11(3):259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8004041</ArticleId><ArticleId IdType="pubmed">33801080</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, et al. Cardiovascular implications of the COVID-19 pandemic: a&#xa0;global perspective. Can J Cardiol. 2020;36(7):1068&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229739</ArticleId><ArticleId IdType="pubmed">32425328</ArticleId></ArticleIdList></Reference><Reference><Citation>AWMF . S3-Leitlinie zur kardiologischen Rehabilitation (LL-KardReha) im deutschsprachigen Raum Europas, Deutschland, &#xd6;sterreich, Schweiz (D-A-CH), Langversion. 2020.</Citation></Reference><Reference><Citation>Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J. 2012;40:255&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">22441750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijn WPE, De Vries J, Wijnen PAHM, Drent M. Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. Respir Med. 2011;105:1388&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">21700440</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS) Br J Health Psychol. 2004;9(Pt 3):279&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">15296678</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>